U.S. manufacturer Moderna plans to start supplying its CoV vaccine to the European Union as early as December – provided the product receives regulatory approval. The company announced this yesterday. It confirmed the conclusion of a framework agreement with the EU Commission. According to the agreement, initially 80 million vaccine doses are to be delivered, with an option for 80 million additional units.
“Moderna expects to begin shipping mRNA-1273 to the European Union in December 2020,” the company confirmed. Strategic partners in Europe are Lonza in Switzerland and Rovi in Spain for the production and filling of the vaccine.
EU Commission President Ursula von der Leyen had already announced the contract for up to 160 million vaccine doses on Tuesday. The Moderna vaccine is one of the three vaccines with the best chances of being approved in Europe within the next few weeks. Prior to this, efficacy and safety will be tested by the EMA (European Medicines Agency). According to the manufacturer, the Moderna vaccine is 94.5 percent effective.
hp, Source: ORF.at/agencies. picture: pixabay.com
This post has already been read 476 times!